142 related articles for article (PubMed ID: 16719542)
21. Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: phase II trial.
Serke M; Schoenfeld N; Loddenkemper R
Anticancer Res; 2004; 24(2C):1211-6. PubMed ID: 15154649
[TBL] [Abstract][Full Text] [Related]
22. Biweekly docetaxel is better tolerated than conventional three-weekly dosing for advanced hormone-refractory prostate cancer.
Hervonen P; Joensuu H; Joensuu T; Ginman C; McDermott R; Harmenberg U; Nyandoto P; Luukkaala T; Hemminki A; Zaitsev I; Heikkinen M; Nilsson S; Luukkaa M; Lehtinen I; Kellokumpu-Lehtinen PL
Anticancer Res; 2012 Mar; 32(3):953-6. PubMed ID: 22399616
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
Bruno R; Hille D; Riva A; Vivier N; ten Bokkel Huinnink WW; van Oosterom AT; Kaye SB; Verweij J; Fossella FV; Valero V; Rigas JR; Seidman AD; Chevallier B; Fumoleau P; Burris HA; Ravdin PM; Sheiner LB
J Clin Oncol; 1998 Jan; 16(1):187-96. PubMed ID: 9440742
[TBL] [Abstract][Full Text] [Related]
24. Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up.
Brunsvig PF; Hatlevoll R; Berg R; Lauvvang G; Owre K; Wang M; Aamdal S
Lung Cancer; 2005 Oct; 50(1):97-105. PubMed ID: 16005105
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients.
Minami H; Kawada K; Sasaki Y; Igarashi T; Saeki T; Tahara M; Itoh K; Fujii H
Cancer Sci; 2006 Mar; 97(3):235-41. PubMed ID: 16542221
[TBL] [Abstract][Full Text] [Related]
26. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
27. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
Pujol JL; Paul S; Chouaki N; Peterson P; Moore P; Berry DA; Salzberg M
J Thorac Oncol; 2007 May; 2(5):397-401. PubMed ID: 17473654
[TBL] [Abstract][Full Text] [Related]
28. A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy.
Kimura Y; Yano H; Taniguchi H; Iwazawa T; Danno K; Kagara N; Kanoh T; Ohnishi T; Tono T; Nakano Y; Monden T; Imaoka S
Jpn J Clin Oncol; 2011 Jun; 41(6):747-51. PubMed ID: 21498408
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.
De Petris L; Migliorino MR; Ceribelli A; Martelli O; Di Molfetta M; Mancuso A; De Santis S; Di Salvia R; De Marinis F
Anticancer Res; 2005; 25(6C):4713-7. PubMed ID: 16334165
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and toxicity of weekly docetaxel in older patients.
Hurria A; Fleming MT; Baker SD; Kelly WK; Cutchall K; Panageas K; Caravelli J; Yeung H; Kris MG; Gomez J; Miller VA; D'Andrea G; Scher HI; Norton L; Hudis C
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6100-5. PubMed ID: 17062686
[TBL] [Abstract][Full Text] [Related]
31. Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.
Syn NL; Wang L; Wong AL; Soe MY; Chuah B; Chan D; Tan SH; Soo RA; Lee SC; Goh BC; Yong WP
Cancer Sci; 2016 Feb; 107(2):173-80. PubMed ID: 26663719
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of docetaxel therapy in patients with advanced hepatocellular carcinoma.
Hebbar M; Ernst O; Cattan S; Dominguez S; Oprea C; Mathurin P; Triboulet JP; Paris JC; Pruvot FR
Oncology; 2006; 70(2):154-8. PubMed ID: 16645329
[TBL] [Abstract][Full Text] [Related]
33. Docetaxel administered on a weekly basis for metastatic breast cancer.
Burstein HJ; Manola J; Younger J; Parker LM; Bunnell CA; Scheib R; Matulonis UA; Garber JE; Clarke KD; Shulman LN; Winer EP
J Clin Oncol; 2000 Mar; 18(6):1212-9. PubMed ID: 10715290
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
Lee JL; Ryu MH; Chang HM; Kim TW; Yook JH; Oh ST; Kim BS; Kim M; Chun YJ; Lee JS; Kang YK
Cancer Chemother Pharmacol; 2008 Apr; 61(4):631-7. PubMed ID: 17520252
[TBL] [Abstract][Full Text] [Related]
35. Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment.
Ramos M; González-Ageitos A; Amenedo M; González-Quintas A; Gamazo JL; Togores P; Losada G; Almanza C; Romero C; Gómez-Martín C
J Chemother; 2003 Apr; 15(2):192-7. PubMed ID: 12797398
[TBL] [Abstract][Full Text] [Related]
36. [Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy].
Yoshida K; Ohta K; Hihara J; Tanabe K; Minami K; Yamaguchi Y; Toge T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1927-32. PubMed ID: 14650961
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
Takigawa N; Segawa Y; Kishino D; Fujiwara K; Tokuda Y; Seki N; Shinkai T; Watanabe Y; Hiraki S; Kozuki T; Gemba K; Tabata M; Kiura K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2004 Sep; 54(3):230-6. PubMed ID: 15127232
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of docetaxel and topotecan in patients with advanced malignancies.
Dubey S; Hutson P; Alberti D; Arzoomanian R; Binger K; Volkman J; Feierabend C; Wilding G; Schiller JH
J Oncol Pharm Pract; 2005 Dec; 11(4):131-8. PubMed ID: 16595064
[TBL] [Abstract][Full Text] [Related]
39. Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.
Schröder CP; de Munck L; Westermann AM; Smit WM; Creemers GJ; de Graaf H; Stouthard JM; van Deijk G; Erjavec Z; van Bochove A; Vader W; Willemse PH
Eur J Cancer; 2011 Jun; 47(9):1355-62. PubMed ID: 21251813
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of docetaxel with concomitant thoracic radiation therapy.
Mauer AM; Masters GA; Haraf DJ; Hoffman PC; Watson SM; Golomb HM; Vokes EE
J Clin Oncol; 1998 Jan; 16(1):159-64. PubMed ID: 9440738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
